University of Bonn scientists reset 80-year-old blood cells to a molecular age under 20 in an Aging Cell study, reigniting ...

Oct 21 (Reuters) - Sweden's EQT will buy molecular testing company Qiagen for about €9.6 billion ($10.78 billion), the ...

Attractive biodistribution supports selection of MP0730 as Radio-DARPin therapy candidate CD70 is a clinically validated target expressed in kidney cancer and other indicationsFirst-in-human program ...

EQT AB is nearing a deal to acquire Qiagen NV for around €9.6 billion ($10.8 billion) bringing an end to years of takeover speculation involving the European molecular testing company, according to ...

At Rutgers Cancer Institute, neuro-oncologists met to discuss the latest trends in precision brain cancer care with FET-PET ...

Decoupling fluid transfer and mixing in an acoustofluidic-enhanced nucleic acid detection system overcomes the macroscopic ...

The growing interest in bioactive peptides has prompted researchers to investigate a diverse range of naturally occurring molecular fragments that may participate in cellular communication, tissue ...

PD-1 bispecific antibodies combine checkpoint blockade with CTLA-4 or VEGF targeting. Can one engineered molecule offer ...

In nematodes, a metabolite induced by the cold links low temperatures to a body-wide signal that promotes longevity. This signalling system is also seen in human cells.

Mycobacterial diseases, including tuberculosis and non-tuberculous mycobacterial infections, remain major global health challenges, particularly as ...

A near-infrared fluorescent choline kinase α inhibitor, JAS239, was used to identify tumors in canine patients.

Researchers developed a drug for Alzheimer's disease, and then discovered that the molecule already exists in human blood, and is found in lower levels in cognitively impaired people.